関連する実験動画
Updated: Feb 22, 2026
08:58
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
17.1K
イブプロフェンの投与量を最適化する:インビヴォおよび仮想の薬物動態学試験からの洞察
David Smrčka1, Sreela Ramesh1, Aleksandra Dumicic1
1Zentiva, k.s., U Kabelovny 130, 10237 Prague, Czech Republic.
まとめ
新しいイブプロフェン二層錠剤 (IR/SR) は,延長された疼痛緩和を提供し,即時放出オプションよりも長く治療レベルを維持します. この配方により,投与頻度を減らすことができ,同時に,薬局外の制限の中で症状の継続的な管理を保証します.
科学分野:
- 薬理学 薬理学とは
- 薬物の配送システムです.
背景:
- イブプロフェンは,一般的なNSAIDであり,痛みと発熱の緩和に広く使用されています.
- 製剤特異の薬剤放出プロファイルは,イブプロフェンの臨床有効性に大きな影響を与えます.
- オーバー・ザ・カウンター (OTC) のイブプロフェンは,最大1日1200mgの投与量を持っています.
研究 の 目的:
- 4つのイブプロフェン製剤の薬物動態プロフィールを体系的に比較する.
- 吸収運動,血濃度-時間プロファイル,治療期間を評価するために.
- 持続的な痛みと発熱管理のための異なるイブプロフェン製剤の適性を評価する.
主な方法:
- In vivo 薬物動力学 (PK) データ収集.
- 仮想シミュレーションのための生理学に基づくPKモデリング.
- 作用の発生と持続のための血濃度値 (6.8μg/mLと10.1μg/mL) の評価.
主要な成果:
- 新型即時および持続放出 (IR/SR) 400 mg二層錠剤は,治療用血濃度を8時間維持し,即時放出 (IR) 製剤と比較して2〜3.5時間の期間を延長しました.
- 仮想PKシミュレーションでは,IR200 mg (6回/日) とIR/SR400 mg (3回/日) のレジメントのみが,OTCの制限範囲内で24時間以上持続した治療レベルを示した.
- IR/SR製剤は,長時間有効性と投与頻度の低下を示した.
結論:
- IR/SR 400 mg の二層イブプロフェン錠剤は,従来のIR製剤と比較して,治療効果を拡大しています.
- この新しい処方箋は,より頻度の低い投与スケジュールで,継続的な痛みと発熱の緩和をサポートします.
- IR/SR製剤は,確立された安全性範囲内で,効果的なOTC疼痛管理のための有望な選択肢です.
関連する概念動画
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
204
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
204
01:20Drug Product Performance: In Vitro–In Vivo Correlation
311
In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while...
311
01:13Bioequivalence studies: Biowaivers
306
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
306
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
255
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
255
01:20Measurement of Bioavailability: Pharmacodynamic Methods
879
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
879
01:16Methods for Studying Drug Absorption: In vitro
662
In vitro experiments are crucial for understanding the transport and absorption of drugs through biological materials. These studies employ varied methods such as the diffusion cell method, the everted sac technique, and the everted ring technique.
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
662